The virus of herpes simplex (HSV) was isolated in experimental animals as long ago as 1920 (Gruter 1920 , Lowenstein 1919 . The method of corneal scarification leading to keratoconjunctivitis in rabbits and guinea pigs is now mainly of historical significance, but mice, and more particularly suckling mice which are highly susceptible to the virus after intracerebral inoculation, are still used for virus isolation (Table I) . A more convenient and highly susceptible method for virus isolation is inoculation of the chorioallantoic membrane (CAM) of the 11-13-day-old chick embryo on which characteristic pock lesions develop and become visible to the naked eye within 48-72 hours (Figure 1) . Nowadays, the virus can also be grown in a variety of tissue culture cells in which characteristic cytopathogenic effects are produced. Rabbit kidney (RK 13), baby hamster kidney (BHK21), human embryo and human amnion cells are the most susceptible, whereas primary monkey kidney cells are relatively insusceptible. Virus growth in tissue culture is easily recognized by the focal cytopathogenic effect characterized by small rounded-up pyknotic cells and sometimes syncytial giant cell formation ( Figure 2 ). 
Structure
Our understanding of herpesviruses was considerably enhanced when their structure was revealed by electron microscopy using the negative-staining technique (Wildy et al. 1960) ( Figure 3 ). Indeed, herpesviruses are now defined on the basis of their structure. The complete virus particle is 180 nm in diameter and consists of a lipoprotein envelope enclosing the nucleocapsid. The nucleocapsid consists of the deoxyribonucleoprotein core surrounded by the capsid or protein coat which is made up of identical morphological subunits (capsomeres) arranged in icosahedral symmetry. In herpesviruses there are 150 hollow hexagonal morphological subunits and 12 pentagonal ones at the 12 vertices of the icosahedron. This morphology is common to a number of viruses which differ in their biological and serological properties; all of these are now included in the genus Herpesvirus.
Antigens
After infection with HSV, the host responds with the production of neutralizing and complement-fixing antibodies to the viral antigens. Although standard tests show all strains to be antigenically uniform, more sophisticated antigenic analysis-in particular neutralization kinetics (Plummer 1964) and quantal neutralization tests (Pauls & Dowdle 1967), as well as immunofluorescence (Geder & Skinner 1971 , Nahmias et al. 1969 ) and gel electrophoresis techniques (Honess & Watson 1974 , Cassai et al. 1975 )~has revealed minor antigenic differences which divide herpes simplex strains into two serological types. Type I strains are recovered from nongenital sites, particularly the oral cavity, whereas Type II strains are recovered almost exclusively from the genital tract. These strains also differ in their biological, biophysical and biochemical properties ( Table 2) .
Classification
The virus of herpes simplex belongs with other viruses of similar morphology to the genus Herpesvirus. Altogether 50 different species of Herpesvirus are known to infect some 30 different vertebrate species and the medically-important ones are listed in Table 3 . They are all DNA viruses which tend to remain latent in the tissues, and some of them infect ectodermal tissues preferentially and produce vesicular lesions.
Laboratory diagnosis
Specimen collection: For laboratory diagnosis virus isolation is the procedure ofchoice. Ideally there should be a minimum of delay between collection of the specimen and inoculation into a suitable laboratory host. Delay of more than a few hours requires refrigeration of the specimen and longer periods require storage of the specimen at -70°C. For ulcers of the mouth, or of other mucous membranes, the lesion is firmly rubbed with a swab moistened in transport medium and the swab expressed into 0.5-1 ml of the medium. Transport medium is a sterile balanced salt solution supplemented with I% bovine serum albumin and suitable antibiotics. In oral infections, saliva is a good source of virus, and from vesicular lesions vesicle fluid collected with a fine needle and syringe is an ideal specimen for virus studies.
Microscopy: On receipt of specimens, virus isolation is usually attempted immediately, but occasionally it is possible to examine clinical material directly by electron microscopy (EM) or by immunofluorescence. Vesicular fluid, which may contain as many as 10 10 particles/rnl, is an eminently suitable specimen for EM examination, after negative staining. The method is particularly useful in differentiating smallpox from herpes simplex or varicella because the brick-shaped virus of smallpox ( Figure 4 ) is easily distinguished from HSV or varicella virus which are morphologically indistinguishable from each other ( Figure 3 ).
Smears made from material scraped from lesions may be stained with fluorescein labelled anti-HSV serum and examined it} U.v. light.
Virus isolation: For virus isolation, which is the most sensitive and unequivocal of the diagnostic tests, all specimens, whether directly examined or not, are inoculated into one or more of the available susceptible hosts. Chick embryo CAM, suckling mice or tissue cultures may be used and final identification of the isolate is made by neutralization tests with specific HSV antiserum.
Virus identification: Viruses which cause vesicular eruptions of the skin or mucous membranes need to be differentiated from HSV. The viruses of smallpox, herpes simplex and varicella may be rapidly differentiated by electron microscopy, tissue culture and CAM inoculation, and by serological tests (Table 4 ). Herpangina is a condition which may be confused with oral herpes. This epidemic febrile illness, characterized by a few vesicular lesions on the soft palate but not on the buccal mucous membrane, is caused by an enterovirus Coxsackie A, which is an RNA virus only 27 nm in diameter and easily distinguishable from HSV. Its growth is confined to suckling mice, in which characteristic symptomatology and post-mortem lesions are produced, but some strains may grow in primary monkey kidney cells with characteristic cytopathogenic effects. , Coxsackie A 16 virus is the cause of another oral condition, hand foot and mouth disease, which may have to be distinguished.
Serology:
In primary infections serological tests on the patient's serum will provide confirmation of herpetic infection diagnosed by virus isolation, or if virus isolation is unsuccessful retrospective diagnosis of herpetic infection is possible. The patient's sera collected in the acute and convalescent phases of the disease are tested for neutralizing or complement-fixing antibodies to herpes virus and a four-fold rise of specific antibody is diagnostic. Since recurrent herpes is usually associated with a high titre of antibody in the acute phase serum, a rise in titre is not usually demonstrable and diagnostic serology is oflittle help in the diagnosis of the recurrent form of herpes.
Epidemiology
Serology clearly differentiates between primary infection which occurs in nonimmunes, and recurrent infection which occurs in those with high and stable levels of antibody. From this, Burnet & Williams (1939) explained the natural history of the disease. They suggested that primary infection is usually acquired in childhood followed by development of antibodies during convalescence. The virus is not necessarily eliminated but may remain latent in the tissues until reactivated by nonspecific stimuli from time to time.
The exact form in which the virus remains latent is not known but may represent a chronic subclinical infection, regulated by the immune system, in which only a few cells are infected producing a low level of virus insufficient to produce symptoms of the disease. Alternatively, some integration of host and virus genome without production of infective virus may occur in latently-infected cells similar to the integration of the bacteriophage genome in lysogenic bacteria.
The location of latent virus is likewise still disputed. HSV has not been recovered by current techniques from the site of recurrent infection during the quiescent phase, but nerve tissue is a possible source of latent virus because section of the posterior root of the trigeminal ganglion for trigeminal neuralgia is frequently followed by herpetic eruptions in the area supplied by the trigeminal nerve (Carton & Kilbourne 1952 , Ellison et al. 1959 . Moreover, it is now well established that HSV can remain latent in sensory ganglia and the virus has been isolated from both sensory and trigeminal ganglia by cocultivation techniques (Nesburn et al. 1972 , Baringer 1974 , Baringer & Swoveland 1973 . This suggests that after initial infection HSV travels centripetally along nerve fibres to the sensory nerve ganglia where it remains latent until reactivated, when it travels back centrifugally to the periphery.
Antibody surveys indicate that the majority of the population have been infected with HSV at some time or another and that 90% or more of these infections are subclinical. Virus may be recovered from the oral secretions as well as the stools of patients suffering from both primary and recurrent infections. The earlier acquisition and more widespread distribution of primary infection in the communities with low social, economic and hygienic standards suggests that. the faecal-oral route of spread may be of some importance. Nevertheless, spread by direct contact remains an important, probably the most important, mode of spread. The frequency of primary infection in children and young adults, the periods of life when oscula tory embraces are customary, suggests that infection is spread by this means. It should not be forgotten that genital infections may be acquired by veneral infection. Treatment J B Kurtz MRcpath Virology Laboratory, Churchill Hospital, Oxford OX] 7LJ
Before considering the treatment of oral herpes simplex virus (HSV) infections, two points in diagnosis must be stressed. First, a picture clinically indistinguishable from a primary HSV infection may be caused by several other microorganisms, e.g. Coxsackie A and Epstein-Barr viruses. It is therefore important to get laboratory confirmation of the clinical diagnosis. Secondly, HSV is most unlikely to cause recurrent stomatitis although the oral cavity may be involved in recurrences in immune deficient or suppressed patients.
II). what is usually a self-limiting infection the objectives of treatment must be clearly defined. Treatment of the primary infection ideally should not only shorten the acute illness with relief of symptoms, but also stop the virus going latent so preventing future recurrences. Although the aim of treating cold sores is usually cosmetic it should also serve to reduce the risk of crossinfection. The unpredictable course of the natural disease also makes assessment of therapy difficult. At present three drugs, all analogues of purine or pyrimidine nucleosides and all of which have a broad spectrum of activity against DNA viruses in vitro, should be considered. In the in vivo situation, however, account must also be taken of the metabolism of the drug, its ability to reach the site of the lesion, and its toxicity to the whole animal.
SInce 5-Iodo-2'-deoxyuridine (IOU), a pyrimidine analogue, was first shown to be effective for the treatment of herpetic keratitis (Kaufman 1962), it has become standard therapy in that condition. IOU penetrates skin poorly and for that reason appeared ineffective in the treatment of skin lesions. By dissolving IOU in dimethyl sulphoxide (OMSO), which promotes penetration, Juel-Jensen & MacCallum (1972) showed its effectiveness in shortening the duration of cold sores. The OMSO itself appeared to have some antiviral activity, and in the experimental situation lowering its pH from 6.5 to 5.0 by the addition of acetic acid enhanced this activity (Allen et al. 1976) . Topical application of 35% IOU in OMSO has also been effective in treating zoster, but no improvement occurred when it was applied to genital lesions caused by HSV Type II. This treatment is not, however, without problems. The OMSO taints the breath with a garlic-like smell and in some people causes a local release of histamine resulting in pain, redness and sometimes bullae. Allergy to IOU may occur on prolonged use and there could be remote risks due to its mutagenic properties.
Cytosine arabinoside (Ara-C), another pyrimidine analogue, is also active in the treatment ofHSV keratitis (Kaufman & Maloney 1963) but it proved too toxic for clinical use. It has been used systemically in the treatment of varicella zoster infections but with very mixed results. The administration by slow intravenous (i.v.) infusion of Ara-C which is rapidly metabolized to inert compounds has, at least in part, been responsible for some of the treatment failures. When given as a single daily i.v. bolus (3 mg/kg/day for 3-5 days) there was a marked reduction of virus shedding in 7 of 8 primary HSV Type I infections (Juel-Jensen 1977) , and no signs of marrow toxicity appeared with this dosage.
Adenine arabinoside (Ara-A), a purine analogue, has yet to find a recognized place in therapy. It is effective when used topically for herpetic keratitis, and when used systemically it has hastened healing of zoster lesions in immunosuppressed patients (Ch'ien et al. 1976) . We have the impression that 1% Ara-A in OMSO is an effective treatment for cold sores. Ara-A, which is considerably less toxic than Ara-C, is also rapidly metabolized, but the product hypoxanthine arabinoside also has some antiviral activity. The disadvantage of Ara-A is its 0141 07687902013402$01.000
